BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2524529)

  • 1. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
    Mehta RL; Takahashi H; Rudick RA; Knutson DW
    J Immunol; 1986 Mar; 136(5):1765-71. PubMed ID: 2936811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
    Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA
    Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.
    Sherwood TA; Virella G
    Clin Exp Immunol; 1986 Apr; 64(1):195-204. PubMed ID: 3731526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
    Taylor RP; Pocanic F; Reist C; Wright EL
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of in vivo immune complex formation and clearance in man.
    Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
    J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
    Emlen W; Carl V; Burdick G
    Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
    Schifferli JA; Ng YC; Estreicher J; Walport MJ
    J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes.
    Seelen MA; Athanassiou P; Lynn WA; Norsworthy P; Walport MJ; Cohen J; Davies KA
    Immunology; 1995 Apr; 84(4):653-61. PubMed ID: 7790040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
    Edberg JC; Kimberly RP; Taylor RP
    Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte complement receptor type 1 and interactions between immune complexes, neutrophils, and endothelium.
    Beynon HL; Davies KA; Haskard DO; Walport MJ
    J Immunol; 1994 Oct; 153(7):3160-7. PubMed ID: 8089493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.